Docplanner Serves 80M Patients Monthly With Under 200 Staff

The Hiring Signal

Docplanner lists 28 product and revenue‑operations roles on its careers portal, a cluster that signals deliberate build‑out, not routine backfill. The hiring wave targets a single objective: rebuild First Class and Media360, the two visibility tiers that drive ARPU across 13 countries, with AI as the default ingredient in every product decision, positioning the company for a public listing while fending off Doctolib and Zocdoc.

The hiring map spans Barcelona, Warsaw, and fully remote contracts within Poland and Spain. Job descriptions for the Product Director, Marketplace role read like a product brief: "Scale our visibility products (First Class, Media360) and evolve pricing and packaging to grow ARPU while delivering clear ROI to doctors." The same posting requires an "AI-first approach. You treat AI as the default ingredient of every product decision, not a feature bolted on at the end — and you've already shipped AI-powered experiences at scale." That language points to centralized product strategy, not localized experiments.

The revenue‑operations hires complement the product push. The Revenue Operations Analyst role describes partnering with global sales teams to analyze local processes, develop global solutions, automate sales processes within CRM, and design dashboards. The Director of GTM Systems & Revenue Technology oversees Salesforce, HubSpot, and AI tooling. Together they build the instrumentation layer that will measure whether AI‑native visibility products actually lift doctor ARPU.

Docplanner's headcount grew 11 percent in the twelve months to mid‑2026, per Welcome to the Jungle data. The company employs between 51 and 200 people on its main entity, but the marketplace serves 130,000 active doctors and 80 million monthly patients across 13 countries. The hiring ratio, 28 open roles against a base that size, is high for a profitable, founder‑led company. It reads like a pre‑IPO investment thesis: lock in the product leadership that can turn a booking marketplace into an AI‑native operating system before public markets ask for proof.

Rebuilding the Visibility Engine

The mandate appears in the senior Product Director posting: "the same mandate." First Class and Media360 are the primary revenue levers for roughly 300,000 paying doctors and clinics across 13 countries.

The marketplace processes 20 million bookings a month from 100 million monthly patient visits across brands including ZnanyLekarz, Doctoralia, MioDottore, Doktortakvimi, and Jameda. The Product Director, Marketplace owns the mandate to "make Docplanner the place where finding and booking the right doctor is effortless — AI-powered search, smarter matching and a frictionless booking flow that sets the standard for healthcare."

The technical backbone is Noa, Docplanner's AI brand for doctors, which already powers an always‑on voice assistant handling inbound calls for smaller clinics. Twilio's case study on that integration reports the assistant "improve[s] patient access, boost bookings for doctors, and improve cost‑efficiency" — a direct ARPU lever.

The re‑platforming mandate, to lead the core marketplace re‑platforming with engineering using modern, scalable foundations for the next decade of growth, ensures the data plumbing can support this scale. For the 300,000 paying doctors, the pitch is simple: every euro spent on visibility returns measurable patients. For Docplanner, the payoff is ARPU growth that compounds at the roughly 25 percent annual clip the company has maintained while profitable — now with AI as the accelerant.

Where Rivals Apply AI

Docplanner's AI visibility push lands in a market where its two largest rivals have already shipped production AI — but at different layers of the stack. Doctolib, the market leader across France, Germany, Italy, and the Netherlands with 90 million patients and 400,000 health professionals, has built its AI roadmap around the clinician's daily workflow. Zocdoc, the U.S. incumbent founded in 2007, has focused recent AI launches on the patient's search and preparation experience. Docplanner's First Class and Media360 overhaul targets a third layer: the marketplace economics that determine whether a doctor stays, pays more, and fills their calendar.

Doctolib's most concrete AI deployments sit inside the practitioner interface. One month before this writing, the company launched what it called its "first fully AI native product" — a consultation assistant that transcribes and structures the clinical note so doctors "don't have to spend their time typing on their keyboards; they can look patients right in the eye." Around it, Doctolib is rolling out a virtual phone assistant for patient booking, a patient data coding tool, a financial assistant, a prevention assistant that mixes patient health data with medical knowledge for tailored prevention at scale, and a medical assistant. The common thread: each tool reduces administrative load for the 400,000 professionals already on Doctolib's software.

A separate, older AI system automates recommendation banners inside the product, including nudges to add SMS reminders to cut no‑shows, feature‑discovery prompts, upsell and downsell propositions. Doctolib's own Medium post reports a 25 percent click‑through rate and 16 percent conversion rate on those banners, six times the performance of standard in‑product campaigns. The same post notes the long‑term goal is a data‑mesh architecture that computes eligibility in real time and becomes the "central orchestrator of user communication through the product." Pilot data cited in an academic case study shows 30 percent fewer no‑shows, 20 percent less admin time, and 40 percent more telemedicine usage; these metrics matter to retention but don't directly move marketplace ARPU.

Zocdoc's recent AI moves are patient‑facing and search‑centric. The company publishes a structured‑information page explicitly designed for LLM consumption, listing mission, products, capabilities, and policies, signaling that it expects AI agents to become a referral source. Zocdoc's model remains a pay‑per‑slot advertising marketplace; its AI investments improve match quality and patient acquisition cost, but the revenue lever is still the slot price doctors bid.

Docplanner's differentiation is structural. First Class and Media360 are paid visibility tiers that control ranking, profile prominence, and lead flow inside a marketplace spanning 13 countries, 2.8 million professionals, and 20 million monthly bookings. The Product Director, Marketplace role is explicitly charged with the same mandate described earlier: scaling visibility products and evolving the pricing/packaging strategy to increase ARPU while ensuring clear ROI for doctors. That mandate, AI that optimizes the marketplace's pricing and allocation logic, has no direct analogue at either competitor. Doctolib monetizes SaaS subscriptions for practice‑management software; Zocdoc monetizes appointment‑slot advertising. Docplanner monetizes marketplace visibility.

The competitive risk is execution speed. Doctolib already has months of live data on its recommendation engine and a consultation assistant in clinicians' hands. Zocdoc has a public LLM‑ready API surface. Docplanner's hiring wave is recent; the AI‑native visibility features are still in development. But the strategic vector is clear: while rivals use AI to deepen existing moats, such as clinical software stickiness for Doctolib and patient acquisition efficiency for Zocdoc, Docplanner is using AI to turn its two‑sided marketplace into a programmable pricing engine.

The IPO Narrative

Docplanner's AI push is not a standalone product initiative — it is the centerpiece of a deliberate IPO narrative. The company has raised $141 million across eight rounds, split evenly between early‑ and late‑stage, with its largest infusion a Series E of $89.9 million in May 2019, per Tracxn data. A subsequent strategic round of roughly $89.6 million, noted by ZoomInfo, extended that runway. The capital built a two‑sided marketplace of the same scale, and more than 20 million monthly bookings. But public‑market investors now demand more than scale; they want evidence that the data flywheel can be monetized at higher margins. AI is the lever.

CEO Mariusz Gralewski confirmed in January 2026 that the company is preparing for a public listing later this year, explicitly tying the timeline to AI‑driven growth. "AI integration could expand patient engagement, optimize clinical operations, and attract investor interest," he said, framing the technology as a strategic inflection point for healthtech companies navigating global markets and regulatory landscapes. The same interview underscored a dual focus on innovation and compliance: "We are committed to ensuring AI enhances patient outcomes while adhering to strict data privacy standards." That phrasing is deliberate; public filings will be scrutinized for GDPR alignment, clinical validation protocols, and cross‑border data flows across Docplanner's European and Latin American footprint.

The market backdrop supports the timing. The European online doctor consultation market was valued at $1.78 billion in 2024 and is projected to reach $14.5 billion by 2033, a 26 percent compound annual growth rate, according to Reed Intelligence. Statista places the broader online doctor consultations market at $10.14 billion in 2025 with a 2.9 percent CAGR through 2030, while a separate Statista series puts it at $2.76 billion in 2025 growing at 3.67 percent. The variance reflects different market definitions, but the trajectory is consistent: digital health adoption accelerated during the pandemic and has not reverted. Historical IPO patterns favor companies that demonstrate scalable technology and sustainable growth; Docplanner's profitability checks the sustainability box, while the AI layer addresses scalability.

Docplanner's repositioning as an AI‑driven clinical workflow platform, expanding its AI Assistant to five countries, is a direct play for a premium valuation. The 30 percent time‑reclamation promise for clinicians, cited in analyst coverage, targets a core healthcare pain point and translates into a tangible ROI metric for the S‑1. Regulatory scrutiny will intensify around data privacy, clinical accuracy, and cross‑border compliance. The company's ability to demonstrate governed, auditable AI deployments across its 13‑country network will be a key diligence item. For now, the hiring surge for senior AI product managers, the re‑platforming of First Class and Media360, and the revenue‑operations buildout form a coherent signal: Docplanner is building the operating metrics and governance infrastructure that public investors will demand.

Inside the Organization

Docplanner's hiring surge for senior product and AI roles brings new leadership into an engineering organization navigating the industry‑wide shift from Copilot to Cursor and, more recently, to Claude Code and Codex. As of late 2025, "every engineering team we talk to is using Cursor," and early Cursor adopters now show "varying degrees of Claude Code and Codex adoption," said Daksh Gupta of Greptile in conversation with Turner Novak. The pattern holds across the sector: teams run multiple tools simultaneously because "you can easily switch between them" and "they all produce an order of magnitude more value than they cost. Maybe 100x more."

But access does not equal mastery. Google disclosed that "more than 25% of its new code is AI‑generated, but it is reviewed by engineers before acceptance," reflecting the emerging norm of human‑in‑the‑loop orchestration, not autonomous agents. The bottleneck has shifted from typing to "human attention, coordination, and integration," Gupta said. Teams that specialize, using Cursor for reviews and Claude for batch operations, see measurably higher output. The risk is visible in the numbers: one team reported shipping "3x more code this quarter and our defect rate tripled." Marc García warned that "AI coding agents amplify what's already present. If your practices are solid, including real TDD, clean architecture, and a strong pairing culture, you're gonna go to the moon. If your practices aren't solid, you're going to crash and burn."

The company's AI Visibility Score sits at 63 out of 100 ("Good" but with headroom), and the hiring wave suggests leadership knows the operating model must change before the tooling pays off.

Twenty‑eight roles posted. By the time the filing goes public, the flywheel between First Class ranking and Media360 conversion will either spin on its own — or it won't. The marketplace remembers what happened to the last visibility platform that promised dynamic pricing without the data to back it.

Working in frontier tech? Zero G Talent tracks the openings: see every open Cursor role, browse frontier tech jobs, the companies hiring, and the people building the field.